Cargando…

Proteomic differences in recombinant CHO cells producing two similar antibody fragments

Chinese hamster ovary (CHO) cells are the most commonly used mammalian hosts for the production of biopharmaceuticals. To overcome unfavorable features of CHO cells, a lot of effort is put into cell engineering to improve phenotype. “Omics” studies investigating elevated growth rate and specific pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommeregger, Wolfgang, Mayrhofer, Patrick, Steinfellner, Willibald, Reinhart, David, Henry, Michael, Clynes, Martin, Meleady, Paula, Kunert, Renate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985663/
https://www.ncbi.nlm.nih.gov/pubmed/26913574
http://dx.doi.org/10.1002/bit.25957
_version_ 1782448098022260736
author Sommeregger, Wolfgang
Mayrhofer, Patrick
Steinfellner, Willibald
Reinhart, David
Henry, Michael
Clynes, Martin
Meleady, Paula
Kunert, Renate
author_facet Sommeregger, Wolfgang
Mayrhofer, Patrick
Steinfellner, Willibald
Reinhart, David
Henry, Michael
Clynes, Martin
Meleady, Paula
Kunert, Renate
author_sort Sommeregger, Wolfgang
collection PubMed
description Chinese hamster ovary (CHO) cells are the most commonly used mammalian hosts for the production of biopharmaceuticals. To overcome unfavorable features of CHO cells, a lot of effort is put into cell engineering to improve phenotype. “Omics” studies investigating elevated growth rate and specific productivities as well as extracellular stimulus have already revealed many interesting engineering targets. However, it remains largely unknown how physicochemical properties of the recombinant product itself influence the host cell. In this study, we used quantitative label‐free LC‐MS proteomic analyses to investigate product‐specific proteome differences in CHO cells producing two similar antibody fragments. We established recombinant CHO cells producing the two antibodies, 3D6 and 2F5, both as single‐chain Fv‐Fc homodimeric antibody fragments (scFv‐Fc). We applied three different vector strategies for transgene delivery (i.e., plasmid, bacterial artificial chromosome, recombinase‐mediated cassette exchange), selected two best performing clones from transgene variants and transgene delivery methods and investigated three consecutively passaged cell samples by label‐free proteomic analysis. LC‐MS‐MS profiles were compared in several sample combinations to gain insights into different aspects of proteomic changes caused by overexpression of two different heterologous proteins. This study suggests that not only the levels of specific product secretion but the product itself has a large impact on the proteome of the cell. Biotechnol. Bioeng. 2016;113: 1902–1912. © 2016 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.
format Online
Article
Text
id pubmed-4985663
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49856632016-08-26 Proteomic differences in recombinant CHO cells producing two similar antibody fragments Sommeregger, Wolfgang Mayrhofer, Patrick Steinfellner, Willibald Reinhart, David Henry, Michael Clynes, Martin Meleady, Paula Kunert, Renate Biotechnol Bioeng Articles Chinese hamster ovary (CHO) cells are the most commonly used mammalian hosts for the production of biopharmaceuticals. To overcome unfavorable features of CHO cells, a lot of effort is put into cell engineering to improve phenotype. “Omics” studies investigating elevated growth rate and specific productivities as well as extracellular stimulus have already revealed many interesting engineering targets. However, it remains largely unknown how physicochemical properties of the recombinant product itself influence the host cell. In this study, we used quantitative label‐free LC‐MS proteomic analyses to investigate product‐specific proteome differences in CHO cells producing two similar antibody fragments. We established recombinant CHO cells producing the two antibodies, 3D6 and 2F5, both as single‐chain Fv‐Fc homodimeric antibody fragments (scFv‐Fc). We applied three different vector strategies for transgene delivery (i.e., plasmid, bacterial artificial chromosome, recombinase‐mediated cassette exchange), selected two best performing clones from transgene variants and transgene delivery methods and investigated three consecutively passaged cell samples by label‐free proteomic analysis. LC‐MS‐MS profiles were compared in several sample combinations to gain insights into different aspects of proteomic changes caused by overexpression of two different heterologous proteins. This study suggests that not only the levels of specific product secretion but the product itself has a large impact on the proteome of the cell. Biotechnol. Bioeng. 2016;113: 1902–1912. © 2016 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc. John Wiley and Sons Inc. 2016-03-16 2016-09 /pmc/articles/PMC4985663/ /pubmed/26913574 http://dx.doi.org/10.1002/bit.25957 Text en © 2016 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Sommeregger, Wolfgang
Mayrhofer, Patrick
Steinfellner, Willibald
Reinhart, David
Henry, Michael
Clynes, Martin
Meleady, Paula
Kunert, Renate
Proteomic differences in recombinant CHO cells producing two similar antibody fragments
title Proteomic differences in recombinant CHO cells producing two similar antibody fragments
title_full Proteomic differences in recombinant CHO cells producing two similar antibody fragments
title_fullStr Proteomic differences in recombinant CHO cells producing two similar antibody fragments
title_full_unstemmed Proteomic differences in recombinant CHO cells producing two similar antibody fragments
title_short Proteomic differences in recombinant CHO cells producing two similar antibody fragments
title_sort proteomic differences in recombinant cho cells producing two similar antibody fragments
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985663/
https://www.ncbi.nlm.nih.gov/pubmed/26913574
http://dx.doi.org/10.1002/bit.25957
work_keys_str_mv AT sommereggerwolfgang proteomicdifferencesinrecombinantchocellsproducingtwosimilarantibodyfragments
AT mayrhoferpatrick proteomicdifferencesinrecombinantchocellsproducingtwosimilarantibodyfragments
AT steinfellnerwillibald proteomicdifferencesinrecombinantchocellsproducingtwosimilarantibodyfragments
AT reinhartdavid proteomicdifferencesinrecombinantchocellsproducingtwosimilarantibodyfragments
AT henrymichael proteomicdifferencesinrecombinantchocellsproducingtwosimilarantibodyfragments
AT clynesmartin proteomicdifferencesinrecombinantchocellsproducingtwosimilarantibodyfragments
AT meleadypaula proteomicdifferencesinrecombinantchocellsproducingtwosimilarantibodyfragments
AT kunertrenate proteomicdifferencesinrecombinantchocellsproducingtwosimilarantibodyfragments